I don't know if PI discloses client dealings. In general, absence of merger is actually a good thing for PI since both companies will pursue R&D efforts separately.

Aurobindo Pharma receives USFDA Approval for Entecavir Tablets

Entecavir tablets are used to treat hepatitis B infection.

Aurobindo Pharma has received the final approval from the US Food & Drug Administration (USFDA) to manufacture and market Entecavir Tablets, 0.5mg and 1mg.

IMS data suggest, entecavir has an estimated market size of $294 million for the 12 months ending June 2015.

The company has now a total of 209 ANDA approvals from the US FDA.

entecavir approval.pdf (74.9 KB)

A friend of mine called up and said as per his estimates Ambika cotton consumption is 10% of total production of Pima and Giza variety. I did my calculation independently and came to about same conclusion.

It’s quite possible that there is some error in the way I am looking at the data.

If not then we should worry about 1) opportunity size and possible growth going forward [Am looking beyond 30K spindles capacity expansion] 2) Availability of cotton itself owing to severe drought in California [it produces > 90% of US Pima cotton production]. In 2015 area under Pima has declined from 2 to 1 Lakh acre [read this article http://www.nytimes.com/2015/08/08/business/a-once-flourishing-pima-cotton-industry-withers-in-an-arid-california.html?_r=1] . Even in Egypt area under Giza cotton is declining due to removal of subsidies on cotton. [http://english.ahram.org.eg/NewsContent/3/12/119530/Business/Economy/New-subsidy-cut-may-be-the-end-of-Egyptian-Cotton.aspx]

Here are my calculations:

For USA

So US is around 13crs Kg . See this link for US area under PIMA cotton http://www.supima.com/view-reports/acreage-estimate/ . Pounds per acre is from NYT article referred above.
Egypt produced 370,000 bales during 2014 . One bale = 225kgs. This amount to 8.3crs kgs
[see this link http://gain.fas.usda.gov/Recent%20GAIN%20Publications/Cotton%20and%20Products%20Annual_Cairo_Egypt_3-30-2014.pdf] 90% of Egypt cotton is extra long and long staple variety.
So Pima + Giza amounts to 21crs kg for 2014. As per Ambika website cotton consumption for 2014 was 1.89 cr kg and for 2015 2.23cr kg. So as per my estimates Ambika is already consuming around 10% of global production. Atleast for next 2-3 yrs it seems global production is not going to increase. So to repeat 1) Opportunity size ???? 2) Availability of cotton ????

Update on the portfolio

PolyMed: Reduced my exposure in PolyMed
- Current weitage in portfolio too high
- Don't see any near term triggers
- like the medical disposable industry, however I think company should have been more successful enough in expanding their product basket

Kitex: closed my position in Kitex.
- feel company should have been more forthcoming clarifying the doubts raised by some our members.
- I don't doubt the management, but I think the reluctance to answer the questions made me rethink about transparency (am I nitpicking?). May add it back in portfolio when the dust settles.

NBCC: added more shares in July to August period. I think it is in a sweet spot. I usually don't invest in public sector companies. However, in the case NBCC interests of GOI and other shareholders are in sync.

Paushak: added in July. It is almost like a monopoly with huge entry barriers.

Shaily: added in July. Good industry segment. Liked it when I saw Ikea and other big MNCs as some of the customers.